242 related articles for article (PubMed ID: 25700975)
1. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.
Merrill MM; Wood CG; Tannir NM; Slack RS; Babaian KN; Jonasch E; Pagliaro LC; Compton Z; Tamboli P; Sircar K; Pisters LL; Matin SF; Karam JA
Urol Oncol; 2015 Apr; 33(4):166.e21-9. PubMed ID: 25700975
[TBL] [Abstract][Full Text] [Related]
2. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
3. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
4. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.
Adibi M; Thomas AZ; Borregales LD; Merrill MM; Slack RS; Chen HC; Sircar K; Murugan P; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
Urol Oncol; 2015 Oct; 33(10):427.e17-23. PubMed ID: 26004164
[TBL] [Abstract][Full Text] [Related]
5. Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.
Eminaga O; Akbarov I; Wille S; Engelmann U
Int Urol Nephrol; 2015 Oct; 47(10):1653-63. PubMed ID: 26329746
[TBL] [Abstract][Full Text] [Related]
6. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
7. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
[TBL] [Abstract][Full Text] [Related]
8. Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
Delacroix SE; Chapin BF; Chen JJ; Nogueras-Gonzalez GM; Tamboli P; Matin SF; Wood CG
J Urol; 2011 Oct; 186(4):1236-41. PubMed ID: 21849197
[TBL] [Abstract][Full Text] [Related]
9. Using percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma.
Kim T; Zargar-Shoshtari K; Dhillon J; Lin HY; Yue B; Fishman M; Sverrisson EF; Spiess PE; Gupta S; Poch MA; Sexton WJ
Clin Genitourin Cancer; 2015 Jun; 13(3):225-30. PubMed ID: 25544725
[TBL] [Abstract][Full Text] [Related]
10. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
11. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcomes after partial vs radical nephrectomy in renal cell carcinomas of ≤7 cm with presumed renal sinus fat invasion on preoperative imaging.
Koo KC; Kim JC; Cho KS; Choi YD; Hong SJ; Yang SC; Ham WS
BJU Int; 2016 Jan; 117(1):87-93. PubMed ID: 25099267
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
14. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.
Thomas AZ; Adibi M; Slack RS; Borregales LD; Merrill MM; Tamboli P; Sircar K; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
J Urol; 2016 Sep; 196(3):678-84. PubMed ID: 27036304
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
[TBL] [Abstract][Full Text] [Related]
16. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
17. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L
J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
19. Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.
Nguyen DP; Vilaseca A; Vertosick EA; Corradi RB; Touijer KA; Benfante NE; Sjoberg DD; Russo P
World J Urol; 2016 Apr; 34(4):539-44. PubMed ID: 26215750
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma.
Paly JJ; Hallemeier CL; Biggs PJ; Niemierko A; Roeder F; Martínez-Monge R; Whitson J; Calvo FA; Fastner G; Sedlmayer F; Wong WW; Ellis RJ; Haddock MG; Choo R; Shipley WU; Zietman AL; Efstathiou JA
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):618-23. PubMed ID: 24411190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
